Multiparametric MRI (mpMRI) is an advanced imaging technique that combines several different MRI sequences to provide a comprehensive evaluation of tissues, which is particularly useful in diagnosing and managing prostate cancer. This approach integrates anatomical and functional imaging by combining T1- and T2-weighted images with additional techniques such as diffusion-weighted imaging, dynamic contrast-enhanced MRI, and sometimes spectroscopic imaging. Combining these modalities enhances the visualization of tissue characteristics, vascularization, and cellular density, offering detailed insights into prostate tumors’ presence, location, and aggressiveness. Multiparametric MRI (mpMRI) has become a critical tool in the clinical pathway for prostate cancer, aiding detection, staging, biopsy guidance, and treatment planning, significantly improving patient outcomes by enabling more accurate and targeted interventions.